Monthly Newsletter

 

VIEW THE LATEST ISSUE

SUBSCRIBE Here

Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Apr 17, 2013 - Pharmaceutical Portfolio & Lifecycle Management

start date: Apr 17, 2013
Print

Event:

Pharmaceutical Portfolio & Lifecycle Management


Starts:
Wednesday, April 17, 2013 at 09:30

Ends:
Thursday, April 18, 2013 at 18:00

Location:
Copthorne Tara Hotel, London, United Kingdom

This is the 8th in this winning annual series and certain to be our best Pharmaceutical Portfolio & Lifecycle Management conference yet!  With 20 expert speakers, 17 in-depth presentations and two interactive half-day workshops this will be the one conference in 2013 to attend for the very latest intelligence to help you develop winning strategies in an increasingly challenging marketplace.

KEY BENEFITS OF ATTENDING:
• Discover current and cutting-edge methods of portfolio management
• Find out how to increase efficiency of a drug lifecycle, in order to create a drug with minimum cost and maximum revenue
• Explore drug pricing and profit: how to read the market to choose the correct cost of a drug
• Learn about the emerging markets in the industry – how this leads to new drug discoveries plus which sectors are becoming increasingly important in drug research and discovery
• Debate lifecycle management techniques and best practices for drug development  including prioritisation, optimisation and management of a drug development portfolio
• Examine the best analysis techniques, which programmes to use, and which methods will gain the most accurate and useful results

SPEAKERS INCLUDE:
Kimber Hardy, Head of Valuation and Analysis, Merck Serono
Lucette Doessegger, Global Head of Licensing & Early Development, F. Hoffmann-La Roche
Michel Hamende, Director, Life Cycle Management, UCB Pharma
Tom Halliwell, Associate Director Programme Manager, Norgine
Richard Fazackerley, Director – Global Demand Chain Technology, Eisai
Gerhard Gross, Head of Drug Metabolism, Lundbeck
Vladimir Anisimov, Senior Strategic Biostatistics Director, Quintiles
Tim Harris, Former Senior Director, Established Products, EMAP, GSK
Mike Rea, Chief Executive Officer, IDEA Pharma UK
and more . . .

PLUS ATTEND TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS

Workshop A | 08.30–12.30| Tuesday 16th April
Current and cutting-edge methods of portfolio management led by Jack Kloeber, Principal, Kromite and Roger Holdsworth, Lead Analyst / Business Development, Kromite

Workshop B | 13.30 – 17.30 | Tuesday 16th April
Successful strategies in lifecycle management led by Tony Ellery,  Chief Executive Officer,
Ellery Pharma Consulting

For further information click here

Media Partners

 

Exhibitions & Events